Streetbeat News

Products Services

MSOS

Ross Gerber delivered a keynote at Benzinga's Cannabis Capital Conference, which could impact cannabis-related stocks and ETFs like MSOS.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:18 pm

CANF

Can-Fite BioPharma has received orphan drug designation from the FDA for its drug Namodenoson, aimed at treating pancreatic cancer. This status can provide benefits like market exclusivity and tax credits, potentially boosting the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:14 pm

BPTH

Bio-Path shares rose as the company launched a new therapeutic program to develop BP1001-A for obesity and related metabolic diseases, marking the first non-cancer application of its DNAbilize technology.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:14 pm

MSOS

Whitney Economics is set to release an executive summary next week, followed by a detailed report. This announcement may have implications for the cannabis industry, potentially affecting related stocks and ETFs.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:09 pm

NVDA

TSM

China's Commerce Minister Wang Wentao expressed serious concerns to U.S. Secretary of Commerce Raimondo about U.S. semiconductor policies and restrictions on Chinese connected vehicles. China urges the U.S. to address these concerns and lift sanctions on Chinese firms.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:08 pm

MSOS

Beau Whitney, Founder & Chief Economist at Whitney Economics, discusses the cannabis market in California, highlighting its potential and challenges. He notes the limited opportunities in cultivation and the importance of understanding regulatory and illicit market issues. As the market evolves, consumer participation is expected to stabilize it.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:08 pm

PPG

PPG has entered a strategic agreement with Shaw Industries to offer its resinous flooring products through Shaw's Patcraft brand, targeting the commercial property market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:05 pm

PRPO

Precipio, Inc. has launched a new version of its Bloodhound MPN panel, which can now distinguish between CALR Type 1 and Type 2 mutations. This advancement aligns with the latest NCCN guidelines and is unique in the market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:04 pm

MSOS

Beau Whitney, Founder & Chief Economist at Whitney Economics, discusses an upcoming report forecasting 2024 total retail sales in the cannabis industry to be around $34 billion. Growth is expected from new and emerging markets, while mature markets are considered saturated.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:03 pm

MSOS

Beau Whitney, Founder & Chief Economist at Whitney Economics, discusses an upcoming report analyzing cannabis market dynamics across different states. The report examines legal consumer participation, licensing needs, and market saturation, suggesting some states may not require new licenses for the next decade.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:01 pm